We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
-0.73%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21B
AUM Growth
-$562M
(-2.6%)
Cap. Flow
-$305M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
43.23%
Holding
256
New
8
Increased
47
Reduced
126
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$92M |
| 2 |
Gilead Sciences
GILD
|
+$86.1M |
| 3 |
Chubb
CB
|
+$11.5M |
| 4 |
EOG Resources
EOG
|
+$8.76M |
| 5 |
State Street
STT
|
+$7.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$55.5M |
| 2 |
Apple
AAPL
|
+$32.3M |
| 3 |
GE Aerospace
GE
|
+$32.1M |
| 4 |
ExxonMobil
XOM
|
+$31.5M |
| 5 |
Kinder Morgan
KMI
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.96% |
| 2 | Energy | 25.29% |
| 3 | Financials | 12.53% |
| 4 | Healthcare | 10.76% |
| 5 | Technology | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Philip Morris
PM
$310B
| $1.58B | 7.51% |
19,255,584
-186,337
| -1% | -$15.1M |
|
|
2
ExxonMobil
XOM
$650B
| $1.5B | 7.15% |
15,353,357
-330,238
| -2% | -$31.5M |
|
3
Coca-Cola
KO
$384B
| $1.25B | 5.95% |
32,312,236
-439,181
| -1% | -$17M |
|
4
Chevron
CVX
$382B
| $880M | 4.19% |
7,397,965
-109,687
| -1% | -$12.8M |
|
5
Altria Group
MO
$125B
| $746M | 3.55% |
19,923,846
-236,628
| -1% | -$8.6M |
|
|
6
Apple
AAPL
$4.98T
| $661M | 3.15% |
34,450,136
-1,696,744
| -5% | -$32.3M |
|
7
T. Rowe Price
TROW
$25.5B
| $660M | 3.15% |
8,014,935
-200
| -0% | -$16.2K |
|
8
Procter & Gamble
PG
$339B
| $654M | 3.12% |
8,122,022
-129,367
| -2% | -$10.2M |
|
9
Johnson & Johnson
JNJ
$640B
| $578M | 2.75% |
5,882,027
-167,188
| -3% | -$15.5M |
|
10
Enterprise Products Partners
EPD
$83.7B
| $567M | 2.7% |
16,360,914
+137,854
| +0.8% | +$4.57M |
|
11
McDonald's
MCD
$193B
| $452M | 2.16% |
4,615,352
-111,389
| -2% | -$10.7M |
|
12
JPMorgan Chase
JPM
$919B
| $396M | 1.89% |
6,529,892
-164,975
| -2% | -$9.53M |
|
13
IBM
IBM
$214B
| $347M | 1.65% |
1,882,534
-41,562
| -2% | -$7.32M |
|
14
ConocoPhillips
COP
$144B
| $345M | 1.65% |
4,909,168
-121,853
| -2% | -$8.16M |
|
|
KMP
15
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
| $341M | 1.63% |
4,614,185
-3,548
| -0.1% | -$276K |
|
16
PepsiCo
PEP
$196B
| $331M | 1.58% |
3,969,828
-90,067
| -2% | -$7.31M |
|
17
Occidental Petroleum
OXY
$55.7B
| $323M | 1.54% |
3,545,462
-48,204
| -1% | -$4.31M |
|
|
NVO
18
Novo Nordisk
NVO
$228B
| $320M | 1.52% |
14,029,022
-445,428
| -3% | -$9.49M |
|
19
Mondelez International
MDLZ
$83.4B
| $314M | 1.5% |
9,081,642
-143,201
| -2% | -$4.89M |
|
20
TotalEnergies
TTE
$193B
| $308M | 1.47% |
4,695,352
-148,142
| -3% | -$9.09M |
|
|
WBA
21
DELISTED
Walgreens Boots Alliance
WBA
| $293M | 1.4% |
4,436,301
-99,751
| -2% | -$6.27M |
|
22
Merck
MRK
$321B
| $288M | 1.37% |
5,327,988
-100,340
| -2% | -$5.2M |
|
|
23
Kinder Morgan
KMI
$70.9B
| $287M | 1.37% |
8,848,378
-677,871
| -7% | -$22.7M |
|
|
RDS.A
24
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $276M | 1.31% |
3,774,017
-255,871
| -6% | -$18.3M |
|
25
AbbVie
ABBV
$466B
| $275M | 1.31% |
5,336,415
-93,150
| -2% | -$4.71M |
|
Similar funds
HF
Fayez Sarofim & Co's Q1 2014 Portfolio in Review
As of Q1 2014, Fayez Sarofim & Co held 256 positions worth $21B, down 2.6% from $21.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Fayez Sarofim & Co's Q1 2014 filing shows 8 new, 47 increased, 126 reduced and 11 closed positions. Its largest new stake was Gilead Sciences: 1,098,306 shares worth $78.4M. The largest sale was Intuitive Surgical, an estimated $55.5M.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 29% a quarter earlier, followed by Energy and Financials.
- Fayez Sarofim & Co's largest Q1 2014 buy was Gilead Sciences: 1,098,306 shares worth $78.4M.
- Fayez Sarofim & Co added most to Union Pacific in Q1 2014, an estimated $92M increase.
- Fayez Sarofim & Co's biggest Q1 2014 reduction was Intuitive Surgical, cutting an estimated $55.5M.
- Fayez Sarofim & Co fully exited State Street SPDR S&P 500 ETF Trust in Q1 2014, selling an estimated $3.03M.
- Fayez Sarofim & Co's ten largest holdings make up 43% of its $21B portfolio in Q1 2014.
- Fayez Sarofim & Co opened 8 new positions and closed 11 in Q1 2014.
- Fayez Sarofim & Co's portfolio value fell 2.6% quarter-over-quarter to $21B.
Based on Fayez Sarofim & Co's 13F filing for Q1 2014, filed 14 May 2014.